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Summary
 
The products of recombination activating gene (RAG)1 and RAG2 initiate the lymphoid-spe-
cific phase of the V(D)J recombination by creating a DNA double-strand break (dsb), leaving
hairpin-sealed coding ends. The next step uses the general DNA repair machinery of the cells
to resolve this dsb. Several genes involved in both V(D)J recombination and DNA repair have
been identified through the analysis of
 
 
 
in vitro mutants (Chinese hamster ovary cells) and in
vivo situations of murine and equine severe combined immunodeficiency (scid). These studies
lead to the description of the Ku–DNA-dependent protein kinase complex and the XRCC4
factor. A human SCID condition is characterized by an absence of B and T lymphocytes. One
subset of these patients also demonstrates an increased sensitivity to the ionizing radiation of
their fibroblasts and bone marrow precursor cells. This phenotype is accompanied by a pro-
found defect in V(D)J recombination with a lack of coding joint formation, whereas signal
joints are normal. Functional and genetic analyses distinguish these patients from the other re-
combination/repair mutants, and thus define a new group of mutants whose affected gene(s) is
involved in sensitivity to ionizing radiation and V(D)J recombination.
Key words: human • immunodeﬁciency • V(D)J recombination • DNA repair • severe 
combined immunodeﬁciency
 
I
 
mmunoglobulin and TCR genes are composed of vari-
able (V),
 
1
 
 diversity (D) and joining (J) segments scattered
along the chromosome that require somatic rearrangement
before their expression (1). The V(D)J recombination proc-
ess is common to both B and T cells and can be divided
into three steps. The initiation of the V(D)J recombination
involves the recognition of recombination-specific sequences
(RSS) flanking the V, D, and J segments by the lymphoid
specific recombination activating gene (RAG)1 and RAG2
proteins. RAG1 and RAG2 then introduce a DNA dou-
ble-strand break (dsb) at the site of the RSS, leaving co-
valently sealed (hairpin) coding ends (2). The critical role
for the RAG proteins in V(D)J recombination has been
demonstrated via targeting experiments in mice (3, 4), and
more recently through the description of human Rag mu-
tants suffering from SCID (reference 5 and our unpub-
lished observations). An intermediate phase in the V(D)J
recombination process is characterized by the recruitment
of the DNA-dependent protein kinase (DNA-PK) com-
plex at the site of the DNA dsb (6). DNA-PK is composed
of a 450-kD catalytic subunit (DNA-PKcs) and a DNA tar-
geting subunit called Ku. Ku itself is a heterodimer of the
70- and 80-kD proteins (Ku70 and Ku80, respectively),
and displays DNA end–binding activity in vitro (7). The
whole DNA-PK complex is essential for the V(D)J recom-
bination/DNA repair processes as illustrated by the analysis
of (
 
a
 
) the murine and equine scid models (8–10), (
 
b
 
) several
Chinese hamster ovary cell (CHO) mutants (11–14), (
 
c
 
)
Ku80 knockout mice (15, 16), and (
 
d
 
) Ku70 knockout exper-
iments (17–19). More specifically, nonsense and frame-shift
 
1
 
Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; cs, catalytic
subunit; D, diversity; dsb, double-strand break; J, joining; PK, protein ki-
nase; RAG, recombination activating gene; RSS, recombination-specific
sequences; T
 
2
 
B
 
2
 
, absence of circulating T and B lymphocytes; V, vari-
able; XRCC, x-ray cross-complementing.
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mutations in the DNA-PKcs encoding gene are responsible
for the murine and equine scid conditions, respectively (20,
21), whereas point mutations in the Ku80 gene have been
found in the x-ray cross-complementing (XRCC)5 com-
plementation group of CHO mutants (22, 23). Alteration
of either one of the DNA-PK complex partners results in a
defect in both V(D)J recombination and DNA repair, iden-
tified by an increased sensitivity to any DNA dsb–causing
agent. The product of the XRCC4 gene (24) is another
important effector, as a defect in this gene is responsible for
the impairment of V(D)J recombination and DNA repair
in the XR1-CHO mutant (11, 12). The final step in V(D)J
recombination results in the rejoining of the coding ends
by a molecular mechanism that is largely unknown thus far,
although several recent studies have suggested the possible
involvement of DNA ligase I and/or DNA ligase IV in this
process (25–29).
A human SCID condition of autosomal recessive inher-
itance is characterized by an absence of circulating T and B
lymphocytes (T
 
2
 
B
 
2
 
), whereas NK cells are present (30).
Absent or aberrant pattern of DQ52-Jh rearrangement of
the immunoglobulin heavy chain locus were demonstrated
in some of the patients with this condition (31), whereas bone
marrow–derived, EBV-transformed B cell lines obtained in
some cases displayed germline status of Ig genes (32). We
demonstrated that marrow cells and fibroblasts from one
subset of T
 
2
 
B
 
2
 
 SCID patients exhibited increased radio-
sensitivity (33). In normally radiosensitive T
 
2
 
B
 
2
 
 SCID,
mutations in the RAG1 or RAG2 genes were recently de-
scribed (reference 5 and our unpublished results). Abnor-
mally radiosensitive human SCID resembles the murine
scid condition, as patients are devoid of mature lympho-
cytes and display ubiquitous increased sensitivity to ionizing
radiation (33). However, normal kinetics of DNA repair af-
ter a 50-Gray 
 
g
 
-radiation, as judged by pulse-field gel elec-
trophoresis, together with normal DNA-PK activity in
vitro, have cast doubt on the hypothesis that this condition
truly corresponds to a V(D)J recombination/DNA repair de-
fect group of mutants (34). To address this question more
directly, we analyzed the V(D)J recombination activity in
RAG1/2-transfected fibroblasts from T
 
2
 
B
 
2
 
 SCID patients
using extrachromosomal recombination substrates. More-
over, we took advantage of a consanguineous family with
three affected children to perform genetic studies using
polymorphic markers flanking genes involved in V(D)J re-
combination/DNA repair processes.
 
Materials and Methods
 
Patients and Cells.
 
Patients P1, P2, P5, P6, P10, P11, P12,
and P15 were characterized by an absence of peripheral CD3
 
1
 
 T
cells and CD19
 
1
 
 B cells (34). For all 
 
T
 
2
 
B
 
2
 
 SCID patients except
P11 and P12 radiosensitivity status was determined on marrow
cells (33, 34). P11 and P12 are the brother and sister of P5 and
were born to related parents (see Fig. 1 
 
A
 
). P10 is a 
 
T
 
2
 
B
 
2
 
 SCID
patient caused by mutation in the RAG2 gene (our unpublished
observation) with no increased cell radiosensitivity. Primary skin
fibroblast cell lines were obtained as previously described (34) and
maintained in complete culture medium consisting of RPMI
1640 (Glutamax; GIBCO BRL, Gaithersburg, MD) supple-
mented with 15% FCS. SV40-transformed fibroblast lines were
obtained by transfection of the SV40 large T antigen encoding
plasmid pLAS-wt (35) and by overgrowth of transformed cells
over nontransformed fibroblasts without other means of selection.
 
DNA End–binding and DNA-PK Activity Assays.
 
DNA-PK ac-
tivity was determined in fibroblast cell extracts as previously de-
scribed (34). In brief, 5 
 
m
 
g of cellular extract were incubated with a
p53 peptide (Promega, Charbonnieres, France) with or without 200
ng of linear DNA as activator. Incorporation of 
 
g
 
[
 
32
 
P] into the pep-
tide was monitored. The MO59J and MO59K human cell lines (36)
were used as negative and positive controls, respectively. For the
DNA end–binding assay, 1 
 
m
 
g whole cell extracts prepared in
DNA-PK lysis buffer were incubated with 0.5 ng of a 
 
32
 
P-labeled
Figure 1. (A) Pedigree and biological status of P5, P11, P12, and P15.
Peripheral blood counts of mature T, B, and NK cells were determined
by FACSÒ immunostaining with anti-CD3, anti-CD19, and anti-CD56
mAbs, respectively. (B) Sensitivity to ionizing radiation in CFU-GM
from P10 and P15. Plating efficiency of marrow cell cultures was deter-
mined after increasing doses (0.5–3 Gray) of g-radiation. Results are ex-
pressed as percentage of survival relative to unirradiated cells. C represents
the survival curve obtained with cells from an age-matched control. P10
shows normal radiosensitivity, whereas the survival curve from P15 cells is
representative of the group of patients showing increased cell radiosensi-
tivity. 
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double-strand oligonucleotide probe (5
 
9
 
-CGCGTGGTACGTAG-
GTCACTCTC-3
 
9
 
) in 1XGR buffer (20 mM Tris, pH 7.5, 2 mM
MgCl
 
2
 
, 0.1 mM EDTA, 0.25 mM dithiothreitol, and 5% glycerol)
with 800 ng of circular plasmid DNA. After 15 min incubation at
22
 
8
 
C the reactions were analyzed by 4% PAGE in 1
 
3
 
 TGE buffer
(50 mM Tris, pH 8.5, 380 mM glycine, and 2 mM EDTA). For su-
pershift experiments, whole cell extracts were preincubated (30 min
at 4
 
8
 
C) with 500 ng anti-Ku70/80 (clone 162, Ab-3 NeoMarkers)
mAb or anti-Rag1 (clone G189-1417; PharMingen, San Francisco,
CA) as control before the addition of the oligonucleotide probe.
 
Transient Transfection Assay for V(D)J Recombination.
 
V(D)J re-
combination assay was performed on SV40-transformed fibro-
blasts using the V(D)J extrachromosomal substrates pHRecCJ and
pHRecSJ (see Fig. 3 
 
A
 
). pHRecCJ was constructed by replacing
the polyoma early region (large T antigen and origin of replica-
tion) from pBlueRec (37) with analogous sequences from SV40
to allow for replication in human cells (38). The recombination
of the pHRecCJ plasmid leads to the formation of a coding joint
upon deletion of the two RSS sites. For signal joint formation
analysis, the two RSS sites were inverted in the pHRecSJ plas-
mid. Recombination of the pHRecSJ plasmid leads to the fusion
of the two RSS (signal-joint) creating a diagnostic ApalI restric-
tion site. 5 
 
3 
 
10
 
6
 
 exponentially growing SV40-transformed fibro-
blasts were electroporated (Easyject, Eurogentec, Angers, France;
setting: 250 V, 1,500 
 
m
 
F, 
 
`
 
 
 
V
 
) in 400 
 
m
 
l of complete culture me-
dium with 2.5 
 
m
 
g of either pHRecCJ or pHRecSJ along with 6 
 
m
 
g
of RAG1, and 4.8 
 
m
 
g of RAG2-encoding genes in eukaryotic
expression vector (gift of M. Oettinger, Department of Molecular
Biology, Massachusetts General Hospital, Boston, MA; reference
39). 48 h after transfection, extrachromosomal DNA was pre-
pared by rapid alkaline lysis (40), digested with DpnI to eliminate
nonreplicated plasmids, and used for transfection of bacteria or
PCR analysis using T3 and T7 primers. The percentage of re-
combination was determined by transforming DH10B bacteria in
the presence of Xgal (5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
d
 
-galacto-
pyranoside) and IPTG (isopropyl-
 
b
 
-thiogalactopyranoside) and
counting the blue colonies. Integrity of the recombined substrates
following V(D)J recombination was analyzed by DNA sequenc-
ing using T3 primer.
 
XRCC4 cDNA Sequence Analysis.
 
Total RNA was extracted
from fibroblasts and reverse transcribed using random hexamers
and Moloney murine leukemia virus reverse transcriptase without
RNase H according to manufacturer’s recommendations (GIBCO
BRL). XRCC4 cDNA was PCR-amplified using XRF1 5
 
9
 
GGGCTGCCTCTTTAAATAAC and XRR1 5
 
9
 
 ATGATG-
TTTTCTTTGTCCTGTTTT primers and TaqAdvantage (Clon-
tech Labs., Inc., Palo Alto, CA) enzyme. Cycling parameters were
30 s of denaturation at 94
 
8
 
C, 30 s of annealing at 50
 
8
 
C, and 2.5
min of extension at 72
 
8
 
C for 30 cycles. PCR products were cloned
into pGemT (Promega) and sequenced using the DYEnamic cy-
cle sequencing kit (Amersham Pharmacia Biotech, Piscataway,
NJ) and the Dye terminator cycle sequencing kit (Perkin-Elmer
Corp., Norwalk, CT) on an ABI377 sequencer (Perkin-Elmer).
 
Genotype Analysis.
 
DNA from P5, P11, P12, and their par-
ents were genotyped using 12 polymorphic microsatellite PCR
markers referenced at Généthon (Evry, France; reference 41):
D2S137 and D2S301 for Ku80; D22S276 and D22S537 for
Ku70; D8S519 and D8S1745 for the DNA-PKcs; D5S2029 and
D5S428 for XRCC4; D13S173 and D13S285 for DNA ligase IV;
and D19S412 and D19S866 for DNA ligase I. The forward prim-
ers of each pair were end-labeled with 
 
g
 
-[
 
32
 
P]ATP using polynu-
cleotide kinase. The amplifications were performed in a final re-
action volume of 17.5 
 
m
 
l containing 100 ng template DNA, 0.2
mM deoxynucleotides, 3 pmol unlabeled reverse primer, 1.5
pmol unlabeled forward primer, 1.5 pmol end-labeled forward
primer, and 0.07 U Taq polymerase (ATGC Biotechnologie,
Noisy-le-Grand, France). PCR conditions consisted of 30 cycles,
each consisting of 45 s at 94
 
8
 
C, 1 min at the annealing tempera-
ture specific for each pair of primers, and 45 s at 72
 
8
 
C. The PCR
products were analyzed by electrophoresis on 5% denaturing
polyacrylamide gels.
 
Results
 
Increased Radiosensitivity in Human T
 
2
 
B
 
2
 
 SCID with Nor-
mal DNA-PK Activity.
 
We previously reported on the
occurrence of human immune deficiency characterized by
Figure 2. (A) DNA end–binding assay using cellular extracts from T2B2 SCID patients P5, P11, P12, and P15. Whole cell extracts were preincubated
for 30 min at 48C or not with specific mAb for Ku70/80 (lanes 3, 6, 9, and 12) or Rag1 (lanes 4, 7, 10, and 13) as control. (B) DNA-PK activity in cel-
lular extracts from P5, P11, P12, and P15. MO59J and MO59K cell lines (36) lacking and containing active DNA-PKcs, respectively, were used as con-
trols. DNA-PK activity was determined in the absence (2) or presence (1) of linear DNA as specific activator. 
630
 
V(D)J Recombination and DNA Repair
 
a lack of both B and T lymphocytes, accompanied by an
increase in radiosensitivity of bone marrow precursor cells
and fibroblasts (33, 34). We here extended our series of pa-
tients with three new cases (P11, P12, and P15). P11 and
P12 are two brothers of the previously described patient,
P5, and were born to related parents (Fig. 1 
 
A
 
). These
three patients were devoid of both mature T and B lym-
phocytes (Fig. 1 
 
A
 
). Bone marrow cells from P5 were pre-
viously shown to be abnormally radiosensitive and cells
from P15 showed the same extent of increased sensitivity
to 
 
g
 
-rays (Fig. 1 
 
B
 
). The radiosensitivity status of marrow
cells from P11 and P12 was not assessed as they are brothers
of P5, but according to the following results (V(D)J recom-
bination assay) one can assume that they would display in-
creased radiosensitivity as well. One striking finding in our
previous report was the normal DNA-PK activity in cellu-
lar extracts from T
 
2
 
B
 
2
 
 SCID with increased cell radiosen-
sitivity (34). DNA-PK activity was also normal in cellular
extracts from the four patients described here (Fig. 2 
 
B
 
), in
contrast to the absence of activity in the DNA-PK negative
MO59J cell line. Given the normal DNA-PK activity in
these patients, it was not surprising to find a functional
Ku70/Ku80 complex in these cellular extracts as tested by
the DNA end–binding assay (Fig. 2 
 
A
 
). The real nature of
the Ku–DNA complex was further proven by supershift
experiments using anti-Ku70/80 mAb, whereas the anti-
Rag1 control antibody did not result in a shift of this com-
plex. Indeed, any defect in this complex would have se-
verely compromised the activation of the DNA-PKcs and
ultimately resulted in the absence of kinase activity as is the
case in various CHO mutants (for review see reference 42).
Altogether, the findings concerning the three newly stud-
ied patients have confirmed and extended the results of our
previous studies.
 
Defective V(D)J Recombination in T2B2SCID Patients with
Increased Cell Radiosensitivity. The “DNA-repair” phase of
the V(D)J recombination can be analyzed by transient
transfection of RAG1, RAG2, and an extrachromosomal
substrate into fibroblasts. The two recombination substrates
used here to analyze both coding and signal joint formation
are depicted in Fig. 3 A. These plasmids were derived from
pBlueRec (37), in which the polyoma large T antigen and
replication origin sequences were replaced by those of
SV40 to allow for replication in human cells (38). In
pHRecCJ, the LacZ gene is interrupted by a DNA stuffer
flanked by two RSS that will be deleted upon coding joint
formation. In pHRecSJ, the two RSS sequences were in-
verted so that the fusion of the two RSS (signal joint) re-
mains on the plasmid after recombination. A functional
LacZ gene is reconstituted upon recombination of the two
plasmids that lead to the formation of blue colonies when
introduced into bacteria and plated on Xgal- and IPTG-
containing medium. The ratio of blue colonies to white
colonies is therefore indicative of the capacity of the cells to
fully accomplish V(D)J recombination. In the case of the
coding joint formation, only one-third of the recombined
substrates will lead to blue colonies because of random nib-
bling of the coding ends, leading to shifts in the LacZ gene
open reading frame (37). In contrast, the signal joint is per-
fect without deletion of nucleotides, so that the number of
blue colonies represent the total number of recombined
substrates. SV40-transformed fibroblast lines from T2B2
radiosensitive SCID patients and two control cell lines (P10
and Hela) were transiently transfected with RAG1 and
RAG2 expression plasmids together with either pHRecCJ
or pHRecSJ. 48 h later the reporter constructs were recov-
ered, digested with DpnI to eliminate plasmids that did not
replicate in the fibroblasts and reintroduced into bacteria,
and the ratio of blue to white colonies was determined (Ta-
ble 1). The recombination frequency ranged from 3.86 3
1023 to 11.06 3 1023 in P10 and Hela cells, respectively,
using the coding joint–specific plasmid pHRecCJ. Sequence
analysis of these recombination products revealed that they
were bona fide coding joints with limited deletions at the
junction (data not shown). P10 is a T2B2 SCID patient
with mutations in the RAG2 gene (our unpublished obser-
vation). P10 belongs to a different group of patients whose
Figure 3. (A) Structure of the V(D)J recombination extrachromosomal
substrates. pHRecCJ and pHRecSJ constructs were adapted from pBlueRec
(37). They contain the SV40 large T coding sequence and the SV40-Ori
for autonomous replication in human cells, and a LacZ gene interrupted
by a 310-bp DNA stuffer flanked by RSS on both sides. pHRecCJ is used
for studying the coding joint formation. In the pHRecSJ plasmid, the two
RSS were inverted to allow for the analysis of signal joint formation. (B)
Analysis of signal joints after pHRecSJ recombination. The recovered
pHRecSJ reporter plasmids were PCR-amplified with T3 and T7 prim-
ers, digested (1) or not (2) by ApalI, and run on a 2% agarose gel. The
500-bp band represents the PCR band obtained from unrecombined
pHRecSJ. The 190-bp band represents the fusion of the RSS in the re-
combined plasmid in the absence of treatment with ApalI. This band is
further digested to a 100-bp fragment with ApalI.631 Nicolas et al.
DNA repair machinery is not affected and whose marrow
cells do not display increased radiosensitivity (Fig. 1 B).
Analysis of signal joint formation in Hela cells using the
pHRecSJ plasmid leads to a recombination frequency of
4.28 3 1023. The V(D)J recombination was assessed in fi-
broblast lines from seven T2B2 radiosensitive SCID pa-
tients and the coding joint formation was found to be pro-
foundly affected in all cases with recombination frequencies
,0.08 3 1023 (Table 1). Interestingly, the frequency of
signal joint formation, determined with the pHRecSJ con-
struct, was not significantly different in these patients com-
pared with the Hela control (mean: 2.55 3 1023). The per-
fect fusion of the heptamer sequences at the signal joint
causes the formation of an ApalI site. This ApalI diagnostic
site was used to check for the integrity of the signal joints
formed in T2B2 SCID cells (Fig. 3 B). The pHRecSJ plas-
mid was PCR-amplified using T3 and T7 primers after
transfection into fibroblasts. The signal joints resulted in a
190-bp PCR fragment that could always be digested into a
100-bp ApalI fragment, indicating the integrity of these
joints in SCID cells. Altogether, these results clearly estab-
lish that the DNA repair machinery necessary for the com-
pletion of the V(D)J recombination is profoundly impaired
in T2B2 SCID with increased cell radiosensitivity.
The Ku80–DNA-PK Complex Is Not Affected in T2B2
SCID Patients with Increased Cell Radiosensitivity. In light of
the molecular defects responsible for the various CHO mu-
tants and the murine and equine scid conditions (8–12, 14, 43),
the functional assay for DNA-PK and Ku activity in human
T2B2 SCID (Fig. 2) implies that the Ku70 and Ku80 pro-
teins are present and capable of binding DNA and recruit-
ing the DNA-PKcs in our series of patients. This also indi-
cates that the DNA-PKcs is expressed with a functional
kinase domain. However, this in vitro assay does not rule
out the possibility of mutations in other, as yet unknown,
domains of these three proteins involved in V(D)J recom-
bination and DNA repair. This limitation is of particular
importance when considering the size (450 kD) of the
DNA-PKcs protein. P5, P11, and P12 are three siblings
from a consanguineous family. In a consanguineous family
it can be assumed that a mutated allele for a given gene will
be inherited as a homozygous trait in affected children and
will be heterozygous in both parents and in healthy sib-
lings. The same holds true for nearby flanking markers.
Therefore, we looked for homozygosity of highly poly-
morphic markers flanking the Ku–DNA-PK complex en-
coding genes in P5 family members. Results of this analysis
(Fig. 4, A–C) showed independent segregation patterns be-
tween these markers and the disease locus in the different
affected children. These results therefore irrevocably ex-
clude the Ku70, Ku80, and DNA-PKcs genes in the T2B2
SCID condition, at least in this family.
XRCC4, Ligase I, and Ligase IV Are Not Involved in T2B2
SCID. Among the various CHO mutants that were
shown to be defective in V(D)J recombination and DNA
repair (for review see reference 44), the XR1 cell line is
characterized by defects in both coding and signal joint for-
mation, but does not show any defect in DNA end–bind-
ing and DNA-PK activities (8, 45, 46). A human cDNA,
called XRCC4, that complements the XR1 defect has
Table 1. V(D)J Recombination Assay in Human T2B2SCID Fibroblasts
pHRecCJ coding joints pHRecSJ signal joints
Blue Total R (3 1023)* Blue Total R (3 1023)‡
Hela Exp. 1 38 10,300 11.06 48 11,200 4.28
P10 Exp. 1 209 96,000 6.53 – – –
Exp. 2 38 29,500 3.86 – – –
P1 Exp. 1 2 109,000 0.05 – – –
P2 Exp. 1 0 54,000 ,0.02 – – –
P5 Exp. 1 8 1,250,000 0.02 24 18,600 1.29
Exp. 2 4 390,000 0.03 15 2,410 6.20
P6 Exp. 1 3 217,000 0.04 11 6,600 1.66
Exp. 2 2 560,000 0.01 243 420,000 0.58
P11 Exp. 1 3 242,000 0.04 8 6,500 1.23
Exp. 2 3 730,000 0.01 49 41,000 1.19
P12 Exp. 1 7 370,000 0.05 14 5,000 2.80
Exp. 2 3 790,000 0.01 196 370,000 0.53
P15 Exp. 1 2 72,000 0.08 23 8,100 2.84
Exp. 2 6 500,000 0.03 36 5,000 7.20
*R (coding joints) 5 3 3 (Blue col.)/(Total col.) 3 1,000.
‡R (signal joints) 5 (Blue col.)/(Total col.) 3 1,000.632 V(D)J Recombination and DNA Repair
been cloned (24). Although cells from human radiosensi-
tive T2B2SCID show normal signal joint formation (Table
1 and Fig. 3 B), the possible involvement of the XRCC4
gene in the pathology was assessed by cDNA sequence
analysis in four unrelated patients (P1, P2, P6, and P11) and
by genotype analysis of flanking polymorphic markers in
P5, P11, and P12 (Fig. 4 D) and in P15 (data not shown).
Normal cDNA sequences (data not shown) and the ab-
sence of cosegregation between flanking markers and dis-
ease inheritance excluded an XRCC4 gene defect as being
responsible for this condition in all patients tested. Re-
cently, the XRCC4 protein has been found to interact
with DNA ligase IV in mammalian cells and stimulate its
activity in vitro (26, 27). Moreover, the yeast counterpart
of DNA ligase IV plays a critical role in DNA dsb repair by
nonhomologous end joining as demonstrated by the in-
crease of radiosensitivity of yeast strains carrying DNA li-
gase IV mutations in a Rad52 defective background (25,
28, 47). Altogether, these reports make ligase IV an attrac-
tive candidate for the religation process during V(D)J re-
combination. Genotype analysis of DNA ligase IV gene
flanking markers in P5, P11, and P12 excluded this gene as
being implicated in the T2B2 SCID condition (Fig. 4 E).
Moreover, cDNA sequence analysis of ligase IV in P15 did
not reveal any mutation in the coding region (data not
shown). This result was perhaps not surprising provided
that the signal joint formation, which can be considered as
a nonhomologous end joining event, was not affected in
these patients (Table 1 and Fig. 3 B). Lastly, another DNA
ligase (ligase I) has been shown to enhance cell-free V(D)J
recombination in vitro (29) and represents another poten-
tial player of the V(D)J recombination reaction. Again,
genotype analysis excluded this gene as being defective in
P5, P11, and P12 (Fig. 4 F). Moreover, an impaired DNA
ligase I activity does not result in a T2B2 SCID phenotype
(48–50) nor does it lead to faulty V(D)J recombination ac-
tivity in vitro (51, 52).
Discussion
Several in vivo conditions are characterized by an ab-
sence of B and T lymphocyte development associated with
a defect in DNA dsb repair. In the murine and equine
SCID conditions a lack of DNA-PK activity caused by
mutations in the DNA-PKcs coding gene are responsible
for the lack of V(D)J recombination (21, 53, 54). Specific
gene targeting of the Ku80 gene also results in a T2B2
phenotype in mice (15, 16), in accord with the V(D)J de-
fect first noted in CHO cells harboring Ku80 mutations
(for review see reference 42). Finally, mice with a targeted
deletion of the Ku70 gene (18, 19) harbor a somewhat sur-
prising phenotype: an absence of B cells but an almost nor-
mal number of mature T lymphocytes. This last result con-
trasts with the profound defect of V(D)J recombination
noted in vitro in embryonic stem cells homozygous for a
Ku70 gene deletion (17) and suggests the existence of T
cell lineage specific factors that complemented the defect in
vivo. The human T2B2 SCID condition we describe is yet
another setting in which early arrest in T and B lympho-
cyte development is most probably caused by a primary de-
fect in the DNA repair/recombination machinery. How-
ever, the factor(s) involved in this pathology are clearly
different from the Ku70-80–DNA-PK complex and from
XRCC4, another factor found to be critical for both V(D)J
recombination and DNA repair in vitro in CHO-XR1 cell
line but for which no in vivo model are yet available (24).
Human RAG11RAG21 T 2B 2 SCID patients therefore
define a new complementation group of mutants whose af-
fected gene(s) are involved in sensitivity to ionizing radia-
tion and V(D)J recombination. The finding of a normal ac-
tivity of signal joint formation in fibroblasts from SCID
patients in vitro indicates that the ultimate ligation step of
the broken ends is probably not affected in these patients.
The exclusion of DNA ligase I and DNA ligase IV as can-
didate genes in three patients certainly strengthens this as-
sumption. The defect in V(D)J recombination in these pa-
tients appears to be specific of the coding joint formation
and may therefore involve enzymatic activities acting
around the resolution of the hairpin-sealed coding ends. A
more general survey of which kind of broken ends cells
from these patients are able or not to repair should help
clarifying the role of the defective molecule(s).
Figure 4. Genotype analysis of P5 family members with highly poly-
morphic microsatellite markers. Lane 1, father; lane 2, mother; lane 3, P5;
lane 4, P11; lane 5: P12. For each gene upstream and downstream mark-
ers were used. None of the markers that are heterozygous in the parents
are found homozygous in the three affected children.633 Nicolas et al.
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